SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : STOCKS WITH ATTITUDE TEAM - FA/TA AND EVERYTHING ELSE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Strauss who wrote (287)12/14/1997 8:19:00 PM
From: Instock  Read Replies (1) of 2377
 
PROFESSIONAL INVESTOR REPORT

12/12 DOW JONES PIR PROFILE IBAH (Q: IBAH)

Provides comprehensive Close 4 Consensus Rec. BUY
product development 52-Week High 8 3/8 4 Analysts 1.8
services to pharma- 52-Week Low 2 7/8 4Q EPS Est 0.03
ceutical, biotechnology, Dividend Yield None 3 Analysts
medical device and Industry Avg 0.90% 3Q Oper EPS 0.03
diagnostic companies; 1997 EPS Est 0.08
services designed to speed 4 Analysts
products from discovery Beta vs DJEI 0.34 1996 Oper EPS 0.06
through development. 5-Yr EPS Growth n.a.
3Q Rev $23.06M +52.7% Industry Avg 18.3%
TTM $83.84M +56.1% P/E Ratio 66.70
3Q Ern $0.71M n.a. Industry Avg 31.37
TTM $1.19M ... Projected P/E 50.00
HQ Blue Bell, PA 1-Yr Tot Rtrn (37.25%)
IR Phone 215-283-0770 Industry Avg 12.93%
(Updated 12/11 Sources: First Call, Market Guide For Help, use N/HLP)

(END) DOW JONES NEWS 12-12-97
08:43 PM EST
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext